Literature DB >> 23532597

Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments.

Sabine Huke1, Raghav Venkataraman, Michela Faggioni, Sirish Bennuri, Hyun S Hwang, Franz Baudenbacher, Björn C Knollmann.   

Abstract

RATIONALE: The Ca(2+) sensitivity of the myofilaments is increased in hypertrophic cardiomyopathy and other heart diseases and may contribute to a higher risk for sudden cardiac death. Ca(2+) sensitization increases susceptibility to reentrant ventricular tachycardia in animal models, but the underlying mechanism is unknown.
OBJECTIVE: To investigate how myofilament Ca(2+) sensitization creates reentrant arrhythmia susceptibility. METHODS AND
RESULTS: Using hypertrophic cardiomyopathy mouse models (troponinT-I79N) and a Ca(2+) sensitizing drug (EMD57033), here we identify focal energy deprivation as a direct consequence of myofilament Ca(2+) sensitization. To detect ATP depletion and thus energy deprivation, we measured accumulation of dephosphorylated Connexin 43 (Cx43) isoform P0 and AMP kinase activation by Western blotting and immunostaining. No differences were detected between groups at baseline, but regional accumulation of Connexin 43 isoform P0 occurred within minutes in all Ca(2+)-sensitized hearts, in vivo after isoproterenol challenge and in isolated hearts after rapid pacing. Lucifer yellow dye spread demonstrated reduced gap junctional coupling in areas with Connexin 43 isoform P0 accumulation. Optical mapping revealed that selectively the transverse conduction velocity was slowed and anisotropy increased. Myofilament Ca(2+) desensitization with blebbistatin prevented focal energy deprivation, transverse conduction velocity slowing, and the reentrant ventricular arrhythmias.
CONCLUSIONS: Myofilament Ca(2+) sensitization rapidly leads to focal energy deprivation and reduced intercellular coupling during conditions that raise arrhythmia susceptibility. This is a novel proarrhythmic mechanism that can increase arrhythmia susceptibility in structurally normal hearts within minutes and may, therefore, contribute to sudden cardiac death in diseases with increased myofilament Ca(2+) sensitivity.

Entities:  

Keywords:  Connexin 43; conduction velocity dispersion; familial hypertrophic cardiomyopathy; myofilament Ca2+ sensitivity; sudden cardiac death; ventricular arrhythmias

Mesh:

Substances:

Year:  2013        PMID: 23532597      PMCID: PMC3850761          DOI: 10.1161/CIRCRESAHA.113.301055

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  69 in total

1.  Dual mechanisms regulating AMPK kinase action in the ischemic heart.

Authors:  Suzanne J Baron; Ji Li; Raymond R Russell; Dietbert Neumann; Edward J Miller; Roland Tuerk; Theo Wallimann; Rebecca L Hurley; Lee A Witters; Lawrence H Young
Journal:  Circ Res       Date:  2005-01-13       Impact factor: 17.367

2.  Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy.

Authors:  Dirk Westermann; Björn C Knollmann; Paul Steendijk; Susanne Rutschow; Alexander Riad; Matthias Pauschinger; James D Potter; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Eur J Heart Fail       Date:  2005-10-07       Impact factor: 15.534

3.  Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy.

Authors:  Norbert Frey; Klara Brixius; Robert H G Schwinger; Thomas Benis; Alex Karpowski; Hans P Lorenzen; Mark Luedde; Hugo A Katus; Wolfgang M Franz
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

4.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; S Sharma; A Varnava; J Poloniecki; E Rowland; W J McKenna
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

5.  Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation.

Authors:  Jose F Ek-Vitorin; Timothy J King; Nathanael S Heyman; Paul D Lampe; Janis M Burt
Journal:  Circ Res       Date:  2006-05-18       Impact factor: 17.367

6.  Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping.

Authors:  G E Morley; D Vaidya; F H Samie; C Lo; M Delmar; J Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  1999-10

7.  Evidence of a dominant backward-propagating "suction" wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy.

Authors:  Justin E Davies; Zachary I Whinnett; Darrel P Francis; Charlotte H Manisty; Jazmin Aguado-Sierra; Keith Willson; Rodney A Foale; Iqbal S Malik; Alun D Hughes; Kim H Parker; Jamil Mayet
Journal:  Circulation       Date:  2006-04-03       Impact factor: 29.690

8.  Key connexin 43 phosphorylation events regulate the gap junction life cycle.

Authors:  Joell L Solan; Paul D Lampe
Journal:  J Membr Biol       Date:  2007-07-15       Impact factor: 1.843

9.  Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.

Authors:  P Melacini; B J Maron; F Bobbo; C Basso; B Tokajuk; M Zucchetto; G Thiene; S Iliceto
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

10.  Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction.

Authors:  Monique C de Waard; Jolanda van der Velden; Virginie Bito; Semir Ozdemir; Liesbeth Biesmans; Nicky M Boontje; Dick H W Dekkers; Kees Schoonderwoerd; Hans C H Schuurbiers; Rini de Crom; Ger J M Stienen; Karin R Sipido; Jos M J Lamers; Dirk J Duncker
Journal:  Circ Res       Date:  2007-03-08       Impact factor: 17.367

View more
  20 in total

1.  Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.

Authors:  Karl Toischer; Wuqiang Zhu; Mark Hünlich; Belal A Mohamed; Sara Khadjeh; Sean P Reuter; Katrin Schäfer; Deepak Ramanujam; Stefan Engelhardt; Loren J Field; Gerd Hasenfuss
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

Review 2.  Linking myofilaments to sudden cardiac death: recent advances.

Authors:  Sabine Huke
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

Review 3.  Research priorities in sarcomeric cardiomyopathies.

Authors:  Jolanda van der Velden; Carolyn Y Ho; Jil C Tardiff; Iacopo Olivotto; Bjorn C Knollmann; Lucie Carrier
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 10.787

Review 4.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

Review 5.  Genetic variations involved in sudden cardiac death and their associations and interactions.

Authors:  Dazhen Wei; Luyuan Tao; Mingyuan Huang
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

6.  Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.

Authors:  Frederik Flenner; Birgit Geertz; Silke Reischmann-Düsener; Florian Weinberger; Thomas Eschenhagen; Lucie Carrier; Felix W Friedrich
Journal:  J Physiol       Date:  2017-02-07       Impact factor: 5.182

Review 7.  Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.

Authors:  Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2017-08-24       Impact factor: 5.460

8.  Pathogenic troponin T mutants with opposing effects on myofilament Ca2+ sensitivity attenuate cardiomyopathy phenotypes in mice.

Authors:  Karissa M Dieseldorff Jones; Yeojung Koh; Rebecca S Weller; Rajdeep S Turna; Ferhaan Ahmad; Sabine Huke; Björn C Knollmann; Jose Renato Pinto; Hyun Seok Hwang
Journal:  Arch Biochem Biophys       Date:  2018-11-13       Impact factor: 4.013

9.  Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.

Authors:  Brian R Thompson; Joshua Martindale; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

10.  Familial hypertrophic cardiomyopathy: is the Frank-Starling law kaput?

Authors:  Sabine Huke; Björn C Knollmann
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.